CRABP2 and neuroblastoma: The high expression level of cellular retinoic acid-binding protein (CRABP)1 and the low expression level of CRABP2 play a role in resistance to RA treatment in breast and pancreatic tumors; however, currently, no specific studies have investigated their roles in neuroblastoma [20–22].